Episodes
100
Latest episode
Sep 2026
Language
EN
Tales from the Heart is a unique collection of educational, inspirational, and enlightening discussions with the stakeholders in the field of cardiology that come straight from the heart. The guests are patients, physicians, healthcare professionals, industry leaders, state and federal regulators and legislators, journalists, and more. Each story delves into the world of the Hypertrophic Cardiomyopathy Associations network and uncovers the true face of HCM from every angle. Patients will inspire you, medical professionals will educate you, and we may even motivate you to learn more and get involved. In season two Tales welcomes new regular co-host including, Dr. Martin Maron, Dr. Harry Lever, Dr Steve Ommen, Dr. Alex de Feria and more!
Live from ESC in Munich, Lisa Salberg and Dr. Martin Maron unpack groundbreaking results from the ACACIA-HCM trial and what they could mean for people with nonobstructive HCM. They discuss improvements in symptoms and exercise capacity, potential changes in heart structure, and a possible path toward a long-awaited new treatment option. Conversation was recorded Aug. 28, 2026
Lisa Salberg and Dr. Michael Ayres discuss how patients and families can recognize changing HCM symptoms and know when to call their care team or seek urgent help. They also tackle back-to-school planning, beta blockers, cardiac scarring, autonomic symptoms and the changing HCM treatment toolbox. Conversation recorded Aug. 21, 2026
Lisa Salberg and Dr. Martin Maron take a fresh look at the long-standing role of beta blockers in HCM and how newer myosin inhibitors are changing the treatment conversation. They also discuss upcoming clinical data, fibrosis, symptom changes, and how patients can better navigate evolving care. This conversation was recorded Aug. 14, 2026
Lisa Salberg and Dr. Alex de Feria explore the growing HCM treatment toolbox, including the innovative SESAME procedure, emerging clinical trials and new possibilities for patients. They also tackle back-to-school planning, hydration, exercise, fatigue and helping children navigate life with HCM. This conversation was recorded August 6, 2026.
Lisa Salberg and Dr. Martin Maron explore new directions in HCM care, including emerging therapies targeting cardiac fibrosis and what researchers are learning about scarring in the heart. They also look ahead to new clinical trial data and answer patient questions about imaging, arrhythmias and the future of HCM treatment. This conversation was recorded July 24, 2026
Lisa Salberg sits down with whistleblower Dinesh Thaker to examine the hidden risks within the generic drug supply chain and why stronger oversight is urgently needed. Together, they discuss drug quality, patient safety, and how advocacy can help drive meaningful change in the healthcare system. This conversation was recorded June 17, 2026.
Lisa Salberg and Dr. Steve Ommen discuss practical ways to stay healthy with HCM during the busy summer months. They also break down promising new drug research, explain what emerging biomarkers mean for patients, and share why planning ahead can help people with HCM enjoy life with greater confidence. This conversation was recorded June 19, 2026.
Lisa Salberg sits down with Dr. Nicholas Smedira of the Cleveland Clinic to explore how HCM surgery has evolved over the past three decades. They discuss myectomy, myosin inhibitors, surgical innovation, patient selection, and why experience and high-volume centers continue to matter in achieving the best outcomes for patients. This conversation was recorded June 8, 2026.
Lisa Salberg welcomes Dr. Ahmed "Sami" Abuzaid to discuss the growth of specialized HCM care in Alaska. They explore building a regional HCM program, expanding access to clinical trials, improving health equity, and what patients need to know about navigating care in remote communities. This conversation was recorded June 5, 2026.
Lisa Salberg welcomes Dr. Christopher Kramer to discuss groundbreaking findings from the international HCMR Registry. They explore how cardiac MRI, scar burden, heart muscle mass, and biomarkers may improve risk prediction and help shape the future of personalized HCM care. This conversation was recorded on May 29, 2026
Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.
Claim this listing
Marvette Lacy, PhD
Michael Michelini: Global Internet Businessman in China, Asia
Jason Graystone & Akil Stokes
Phil Rogacki & Jared Abrojena
MUSICHYPEBEAST
